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Abstract: The deposition of amyloid-like ﬁbrils, composed pri-
marily of the 99-residue protein  2-microglobulin ( 2m), is one of
the characteristic symptoms of dialysis-related amyloidosis. Fibrils
formed in vitro at low pH and low salt concentration share many
properties with the disease related ﬁbrils and have been exten-
sively studied by a number of biochemical and biophysical
methods. These ﬁbrils contain a signiﬁcant  -sheet core and have
a complex cryoEM electron density proﬁle. Here, we investigate
the intrasheet arrangement of the ﬁbrils by means of 15N-13C
MAS NMR correlation spectroscopy. We utilize a ﬁbril sample
grown from a 50:50 mixture of 15N,12C- and 14N,13C-labeled  2m
monomers, the latter prepared using 2-13C glycerol as the carbon
source. Together with the use of ZF-TEDOR mixing, this sample
allowed us to observe intermolecular 15N-13C backbone-to-
backbone contacts with excellent resolution and good sensitivity.
The results are consistent with a parallel, in-register arrangement
of the protein subunits in the ﬁbrils and suggest that a signiﬁcant
structural reorganization occurs from the native to the ﬁbril state.
 2-Microglobulin ( 2m) is a 99-residue protein that forms
amyloid ﬁbril deposits associated with dialysis-related amyloidosis
(DRA).
1 Under acidic conditions (pH ) 2.5) and low salt
concentration, the protein can also form amyloid ﬁbrils in Vitro
through a nucleation-dependent mechanism.
2,3 These ﬁbrils are long,
straight, and unbranched in appearance (Figure S1) and share many
properties with the ﬁbrils isolated from tissues of DRA patients,
including the same characteristic amide I′ band in FTIR spectra.
4
It has been shown that the ﬁbrils themselves, and not the preﬁbrillar
oligomeric species formed in the lag phase of assembly, can disrupt
model membranes and are toxic to cells.
5 While an atomic structural
model for these ﬁbrils is not yet available, structural details emerged
ﬁrst through methods like limited proteolysis,
6,7 hydrogen exchange,
8,9
and more recently by magic angle spinning (MAS) NMR,
10
electron paramagnetic resonance (EPR),
11 and cryo-electron
microscopy (cryoEM).
12 In particular, analysis of the chemical
shifts of 64 assigned residues of  2m ﬁbrils has shown that the
protein contains a rigid ﬁbril core with substantially more  -sheet
character than the native protein.
10 CryoEM maps revealed a
complex picture of the ﬁbrils, where non-native globular  2m
monomers pack in “dimer-of-dimers” building blocks that
associate asymmetrically into crescent-shaped units.
12 In addi-
tion, site-directed EPR spin labeling suggested that the major
building block consists of six  2m polypeptide chains, arranged
in a parallel, in-register manner.
11
In the experiments described here, we investigate the tertiary
structure of  2m amyloid ﬁbrils with 15N-13C MAS NMR correla-
tion spectroscopy. MAS NMR has been successfully used to obtain
information about the inter- and intramolecular interactions that
form the  -sheet core of amyloid ﬁbrils, including A (1-40),
13 a
22-residue fragment of  2m,
14 Het-s(218-289),
15 and curli amy-
loid.
16 Various sample preparation techniques and experiments have
been employed to achieve that end, including methods that rely on
the incorporation of single labels
17,18 or proton-mediated transfer.
19
Here, we use ZF-TEDOR (z-ﬁltered transferred echo double
resonance) mixing
20,21 to obtain intermolecular 15N-13C correla-
tions that establish that the protein subunits in long, straight  2m
ﬁbrils formed at pH 2.5 are arranged as parallel, in-register  -sheets.
Our experiments utilize ﬁbrils formed from a 50:50 mixture of
15N,12C- and 14N,13C- labeled  2m monomers, the latter half being
prepared using [2-13C]-glycerol as the carbon source. This sample,
referred to as “mixed 2- 2m”, offers improved resolution in the
13C dimension
22-24 (Figure 1a) as well as potential gains in
experimental transfer efﬁciency due to the signiﬁcantly reduced
number of directly bonded 13C atoms.
25 The absence of 13C
J-couplings and the elimination of strong (intramolecular) dipolar
15N-13C couplings as a result of the mixed nature of the sample
improve the efﬁciency of ZF-TEDOR.
20,26,27
In a 100% uniformly 15N,13C labeled  2m sample, the experi-
mental one-bond 15N-13C transfer efﬁciency after 1.76 ms of ZF-
TEDOR mixing is typically ∼20% of the 13C CP signal. In the
mixed 2- 2m sample, after such a short mixing time, no signiﬁcant
buildup of 13C polarization is observed, as shown in Figure 1b.
This is due to the absence of 13C nuclei in the 15N,12C-labeled
monomers, which were prepared using 13C-depleted glucose (99.9%
purity) to eliminate contributions from natural abundance. In
particular, signals from one-bond 15N-13C interactions are not
detected. On the other hand, longer ZF-TEDOR mixing times lead
to the buildup of 13C intensity, which reaches a maximum at 18
ms (Figure 1c and Figure S2) and is consistent with 15N-13C
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Figure 1. (a) 13C CP spectrum of mixed 2- 2m ﬁbrils, 512 scans; (b) ZF-
TEDOR spectrum obtained with τmix ) 1.76 ms, 512 scans;, (c) ZF-TEDOR
with τmix ) 18 ms, 5120 scans.
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for the CR region is ∼3%, which is better than the experimental
transfer efﬁciencies observed for uniformly 13C labeled samples
(<1% for similar distances).
20
In order to obtain site-speciﬁc information regarding the origin
of the 15N-13C intermolecular contacts in mixed 2- 2m, we recorded
a 2D ZF-TEDOR experiment with τmix ) 16 ms (Figure S3). This
spectrum presents excellent resolution (13C line widths ∼50 Hz)
and sufﬁcient sensitivity after a long acquisition period, which was
facilitated by the robustness of the TEDOR sequence. Overall, the
positions of the observed cross-peaks in this mixed 2- 2m spectrum
correspond exactly with the positions of cross-peaks in one-bond
(Figure 2a) or two-bond TEDOR spectra (data not shown) of a
 2m ﬁbril sample prepared from 100% 15N, 2-13C glycerol labeled
material (2- 2m). The majority of the cross-peaks in the mixed
2- 2m sample could be readily assigned based on known chemical
shifts of long, straight  2m ﬁbrils,
10 and they correspond exclusively
to intermolecular Ni-CRi,N i-CRi-1,N i-COi,o rN i-COi-1 transfer
(Figures 2b and S3). In particular, the following residues giving
rise to intermolecular contacts in the mixed 2- 2m sample were
assigned: H31-S33, N42, G43, R45, I46, V49, H51-F62, P72,
T73, and Y78-V82. While P32, S33, G43, F56, S57, K58, and
F62 are part of well-ordered loops in the ﬁbrils, the remainder of
the residues represent all of the currently assigned ﬁbril  -strands.
Some cross-peaks in Figure 2b (mixed 2- 2m) do not presently
have assignments. Conversely, not all of the strong cross-peaks
shown in Figure 2a (2- 2m) appear in the mixed 2- 2m spectrum.
This includes G18, G29, E44, H84, and V85 (shown in gray in
Figure 2a) among others. This is most likely due to differences in
local dynamics and relaxation whose effects are exacerbated at long
mixing times, resulting in large variations in the cross-peak
intensities.
30
The data presented above suggest that long, straight  2m ﬁbrils
grown at pH 2.5 and low salt concentration form parallel, in-register
 -sheets. In such a case the average distances for intermolecular
Ni-CRi and Ni-CRi-1 contacts are ∼5 and ∼5.5 Å respectively
(Figure S4), which is consistent with the bulk ZF-TEDOR buildup
(Figure S2). In order to accommodate such an arrangement, substantial
reorganization of the native antiparallel  -sheet structure
31-33 is
required, indicating that the structure of the monomers within the ﬁbrils
must be highly non-native. Figure 3 highlights two clear pieces of
evidence for the non-native structure of  2m within ﬁbrils: ﬁrst, residues
involved in loops/turns in native  2m (Figure 3a) reorganize to form
ordered  -strands in the ﬁbrils (Figures 3b and S5), and second, while
all  -strands form antiparallel  -sheet contacts with residues distant
in sequence in native  2m,  -strands in the ﬁbrils are parallel and in
register.
The parallel arrangement of the  -strands in  2m ﬁbrils was
predicted initially by FTIR experiments
34,35 and is in agreement
with data obtained by site-directed spin labeling and EPR.
11 The
results described here verify and expand upon the latter, which
indicates that spin labels attached to cysteine-substituted residues
S33, S55, S61, and T73 among others give EPR spectra indicative
of immobile, parallel, and in-register stacked spin labels (Figure
S5). Stacks of six  2m monomers arranged in that manner are then
required to fulﬁll the electron density maps obtained by cryoEM.
12
The site-speciﬁc information regarding the intermolecular arrange-
ment of  2m ﬁbrils presented here provides an important step toward
a full molecular model of the ﬁbrils. Additional experiments,
particularly aimed at determining the quaternary fold of the ﬁbrils,
are in progress and should shed light on how this tertiary ﬁbril
arrangement ﬁts into such a complex cryoEM electron density
proﬁle.
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Figure 2. Comparison of the 15N-13CR region of correlation spectra
obtained with ZF-TEDOR mixing for two differently labeled  2m ﬁbril
samples. (a) 2- 2m, τmix ) 1.6 ms, 12 mg of sample, 2 days of experimental
time. Labels correspond to intramolecular Ni-CRi transfer, unless otherwise
noted, while labels in gray denote cross-peaks that appear only in the 2- 2m
spectrum. (b) Mixed 2- 2m, τmix ) 16 ms, 16 mg of sample, 9 days of
experimental time. Labels correspond to intermolecular Ni-CRi or Ni-CRi-1
transfer, unless otherwise noted.
Figure 3. (a) Crystal structure of native monomeric  2m (PDB ID: 1DUZ)
28
showing the antiparallel  -sheet arrangement of the strands (labeled A to
G). (b) Residues that form  -strands in ﬁbrillar  2m painted onto the native
fold.  -Strands in the ﬁbrils
10 are shown as thick tubes, and the residues
giving rise to assigned intermolecular Ni-CRi cross-peaks are shown in
black. The structures were prepared using the Chimera software.
29
17078 J. AM. CHEM. SOC. 9 VOL. 132, NO. 48, 2010
COMMUNICATIONSSupporting Information Available: Sample and experimental
details; EM image of the ﬁbrils; 1D ZF-TEDOR buildup; full 2D ZF-
TEDOR spectrum; expected intermolecular distances in a parallel, in-
register arrangement; summary of the available sequence-speciﬁc
structural information for the ﬁbrils. This material is available free of
charge via the Internet at http://pubs.acs.org.
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